- Home
- TSHA vs AFRI Comparison
TSHA vs AFRI Comparison
Compare TSHA & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- AFRI
- Stock Information
- Founded
- TSHA 2019
- AFRI 1943
- Country
- TSHA United States
- AFRI Gibraltar
- Employees
- TSHA N/A
- AFRI N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- AFRI Packaged Foods
- Sector
- TSHA Health Care
- AFRI Consumer Staples
- Exchange
- TSHA Nasdaq
- AFRI Nasdaq
- Market Cap
- TSHA 262.4M
- AFRI 231.2M
- IPO Year
- TSHA 2020
- AFRI N/A
- Fundamental
- Price
- TSHA $1.24
- AFRI $8.55
- Analyst Decision
- TSHA Strong Buy
- AFRI
- Analyst Count
- TSHA 8
- AFRI 0
- Target Price
- TSHA $6.63
- AFRI N/A
- AVG Volume (30 Days)
- TSHA 2.4M
- AFRI 12.1K
- Earning Date
- TSHA 05-13-2025
- AFRI 04-30-2025
- Dividend Yield
- TSHA N/A
- AFRI N/A
- EPS Growth
- TSHA N/A
- AFRI N/A
- EPS
- TSHA N/A
- AFRI N/A
- Revenue
- TSHA $8,333,000.00
- AFRI $325,098,000.00
- Revenue This Year
- TSHA N/A
- AFRI N/A
- Revenue Next Year
- TSHA N/A
- AFRI N/A
- P/E Ratio
- TSHA N/A
- AFRI N/A
- Revenue Growth
- TSHA N/A
- AFRI 15.94
- 52 Week Low
- TSHA $1.05
- AFRI $8.05
- 52 Week High
- TSHA $4.32
- AFRI $12.00
- Technical
- Relative Strength Index (RSI)
- TSHA 40.35
- AFRI 46.07
- Support Level
- TSHA $1.05
- AFRI $8.50
- Resistance Level
- TSHA $1.36
- AFRI $9.10
- Average True Range (ATR)
- TSHA 0.17
- AFRI 0.42
- MACD
- TSHA -0.01
- AFRI 0.03
- Stochastic Oscillator
- TSHA 25.68
- AFRI 47.12
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.